Substance use and psychotic disorders, seizures, neurocognitive disorders (including Alzheimers disease and dementia), coagulation disorders, cardiometabolic disorders (heart attack, heart failure, ischemic stroke, and hemorrhagic stroke, pulmonary embolism, pulmonary hypertension, coagulopathy and clotting disorders) chronic kidney disease, COPD, pneumonia, liver failure, inflammatory bowel disease, liver cancer) all significantly declined
It comes in the form of a shot or pills
Switching Between Them: From Mounjaro to Semaglutide: Take last Mounjaro dose Wait one week Start semaglutide at 0.5-1.0 mg (provider determines dose) Adjust based on response From Semaglutide to Tirzepatide: Take last semaglutide dose Wait one week Start tirzepatide at 2.5-5 mg (provider determines dose) Escalate according to standard protocol Switching is safe and common
Bellizzi V
Youll receive your first microdose during this visit, and well teach you exactly how to self-administer future doses if you choose take-home options
When will I feel results from NAD+ IV therapy